Skip to main content

Table 3 Prevalence for HERV-K113 and HERV-K115 in different populations

From: Increased seroreactivity to HERV-K10 peptides in patients with HTLV myelopathy

Population Total samples HERV-K113+ (%) HERV-K115+ (%) HERV-K113+ (%)
VBD 30 2(7) 6(20) 8(27)
LGLL 3 1(33) 0(0) 1(33)
HTVLt 24 0(0) 4(17) 4(17)
HTVLm 13 0(0) 1(8) 1(8)
HTVLn 11 0(0) 3(27) 3(27)
MS 24 4(17) 4(17) 8(33)